Minneman K P, Wurtman R J
Annu Rev Pharmacol Toxicol. 1976;16:33-51. doi: 10.1146/annurev.pa.16.040176.000341.
Only recently have a sufficient number of publications been available to legitimize a review of the pharmacology of the mammalian pineal organ. Two decades ago Kitay & Altschule reviewed the world literature on pineal physiology, which comprises several thousand papers, and concluded only that removal of the pineal, or administration of pineal extracts, somehow affected pigmentation in lower vertebrates and gonadal function in mammals (1). As the studies described below demonstrate, much more information is now available concerning the pharmacology of the pineal. This review subdivides present knowledge into two areas: (a) the effects on mammals of administering pineal extracts or pure synthetic or natural pineal constituents and (b) the effects of drugs and hormones on the pineal itself. As might be anticipated, the bulk of studies cited in both categories deals with the pineal hormone, melatonin. Melatonin was first isolated from bovine pineal extracts in 1958 by Lerner and his colleagues (2), who used as a marker the capacity of the hormone to aggregate the pigment granules in amphibian melanophores around the cell nucleus. Five years later, Wurtman et al (3) showed that melatonin affected a physiological function in mammals, that is, the size and secretion of the ovary, and subsequent studies have demonstrated that melatonin administration also modifies the growth, composition, and functional activities of numerous other organs. Only recently an assay was developed that allows quantification of the melatonin in human urine (4). The concentrations of the compound vary with a characteristic daily rhythm, peaking at night. The pineal's apparent role as the sole or major source of melatonin, the presence of melatonin in urine, and the demonstration that physiologic effects follow a pinealectomy or the administration of melatomin seem to justify labeling it a pineal hormone. Melatonin synthesis and pineal biosynthetic activity are generally controlled by the sympathetic nerves of this organ (5,6). Therefore, it should not be surprising that drugs known to modify the synthesis, release, or metabolism of norepinephrine in peripheral organs also affect pineal function. Melatonin is itself a derivative of another biogenic amine, serotonin, whose metabolism and actions are also affected by numerous drugs. Indeed, the pineal has often provided an apt tool for examining monoaminergic mechanisms for pharmacologists not specifically concerned with its particular functional properties.
直到最近才有足够数量的出版物,使对哺乳动物松果体器官药理学的综述具有合理性。二十年前,基泰(Kitay)和阿尔茨舒勒(Altschule)综述了世界范围内有关松果体生理学的文献,其中包含数千篇论文,他们仅得出结论:摘除松果体或给予松果体提取物,在某种程度上会影响低等脊椎动物的色素沉着和哺乳动物的性腺功能(1)。正如下面所描述的研究表明,现在有了更多关于松果体药理学的信息。本综述将现有知识细分为两个领域:(a)给予松果体提取物或纯合成或天然松果体成分对哺乳动物的影响,以及(b)药物和激素对松果体本身的影响。可以预料,这两类中引用的大部分研究都涉及松果体激素褪黑素。1958年,勒纳(Lerner)及其同事首次从牛松果体提取物中分离出褪黑素(2),他们将该激素使两栖动物黑素细胞中的色素颗粒聚集在细胞核周围的能力用作标记。五年后,伍特曼(Wurtman)等人(3)表明褪黑素会影响哺乳动物的一种生理功能,即卵巢的大小和分泌,随后的研究表明,给予褪黑素还会改变许多其他器官的生长、组成和功能活动。直到最近才开发出一种能够对人尿中的褪黑素进行定量的检测方法(4)。该化合物的浓度随每日特有的节律变化,在夜间达到峰值。松果体作为褪黑素唯一或主要来源的明显作用、尿液中褪黑素的存在,以及松果体切除或给予褪黑素后会产生生理效应的证明,似乎都证明将其称为松果体激素是合理的。褪黑素的合成和松果体的生物合成活性通常受该器官的交感神经控制(5,6)。因此,已知能改变外周器官中去甲肾上腺素合成、释放或代谢的药物也会影响松果体功能,这并不奇怪。褪黑素本身是另一种生物胺血清素的衍生物,其代谢和作用也受多种药物影响。事实上,对于并非特别关注松果体特定功能特性的药理学家来说,松果体常常是研究单胺能机制的一个合适工具。